<DOC>
	<DOCNO>NCT02506998</DOCNO>
	<brief_summary>The purpose study determine change quality life patient allergic rhinoconjunctivitis treat standard medication plus Dialyzable Leukocyte Extracts ( DLE ) . All patient receive DLE combination current guide lines-suggested standard medication .</brief_summary>
	<brief_title>Quality Life Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts</brief_title>
	<detailed_description>DLE heterogenous mixture peptides 10 kilo Daltons ( kDa ) obtain disruption peripheral blood leukocytes healthy human donor . DLE report improve clinical response allergy , asthma atopic dermatitis . The therapeutic effect DLE relate immune modulatory effect change innate signal pathway , Toll Like Receptors , Nuclear Factor -kappa B ; production cytokine might also modify use DLE , include Tumor Necrosis Factor , Interleukin ( IL ) -6 , induction Interferon-g secretion , drive immune response T-helper Th1 immune-regulatory response , thus help reduce allergy symptom .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Histamine</mesh_term>
	<mesh_term>Histamine phosphate</mesh_term>
	<mesh_term>Histamine H1 Antagonists , Non-Sedating</mesh_term>
	<mesh_term>Histamine Antagonists</mesh_term>
	<mesh_term>Histamine H1 Antagonists</mesh_term>
	<criteria>Confirmed diagnosis symptomatic seasonal perennial allergic rhinitis Active rhinoconjunctivitis Six week standard treatment inclusion Confirmation Immunoglobulin Emediated response previous positive skin vitro allergen test Other immunological immunemediated disease autoimmune disease cancer . Unstable chronic disease , diabetes , cardiac disease , chronic kidney failure , chronic hepatic disease .</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Allergic rhinoconjunctivitis</keyword>
	<keyword>Dialyzable Leukocyte Extracts</keyword>
</DOC>